These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 28728454)

  • 1. Quantification of marrow hematogones following autologous stem cell transplant in adult patients with plasma cell myeloma or diffuse large B-cell lymphoma and correlation with outcome.
    Santiago V; Lazaryan A; McClune B; McKenna RW; Courville EL
    Leuk Lymphoma; 2018 Apr; 59(4):958-966. PubMed ID: 28728454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The knowledge on the 3rd type hematogones could contribute to more precise detection of small numbers of precursor B-acute lymphoblastic leukemia.
    Babusíková O; Zelezníková T; Mlcáková A; Kusenda J; Stevulová L
    Neoplasma; 2005; 52(6):502-9. PubMed ID: 16284697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendritic cells in autologous hematopoietic stem cell transplantation for diffuse large B-cell lymphoma: graft content and post transplant recovery predict survival.
    Dean R; Masci P; Pohlman B; Andresen S; Serafino S; Sobecks R; Kuczkowski E; Curtis J; Maciejewski J; Rybicki L; Kalaycio M; Hsi E; Theil K; Bolwell BJ
    Bone Marrow Transplant; 2005 Dec; 36(12):1049-52. PubMed ID: 16247431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow cytometric minimal residual disease monitoring in patients with multiple myeloma undergoing autologous stem cell transplantation: a retrospective study.
    Liu H; Yuan C; Heinerich J; Braylan R; Chang M; Wingard J; Moreb J
    Leuk Lymphoma; 2008 Feb; 49(2):306-14. PubMed ID: 18231918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunophenotypic analysis of hematogones (B-lymphocyte precursors) and neoplastic lymphoblasts by 4-color flow cytometry.
    McKenna RW; Asplund SL; Kroft SH
    Leuk Lymphoma; 2004 Feb; 45(2):277-85. PubMed ID: 15101712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiparameter flow cytometric analysis reveals low percentage of bone marrow hematogones in myelodysplastic syndromes.
    Maftoun-Banankhah S; Maleki A; Karandikar NJ; Arbini AA; Fuda FS; Wang HY; Chen W
    Am J Clin Pathol; 2008 Feb; 129(2):300-8. PubMed ID: 18208811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow cytometric DNA quantification in immunophenotyped cells as a sensitive method for determination of aneuploid multiple myeloma cells in peripheral blood stem cell harvests and bone marrow after therapy.
    Nowak R; Oelschlägel U; Range U; Bergmann S; Bornhäuser M; Hölig C; Schuler U; Krebs U; Günther H; Kroschinsky F; Ehninger G
    Bone Marrow Transplant; 1999 May; 23(9):895-900. PubMed ID: 10338044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotyping studies of clonotypic B lymphocytes from patients with multiple myeloma by flow cytometry.
    Conway EJ; Wen J; Feng Y; Mo A; Huang WT; Keever-Taylor CA; Hari P; Vesole DH; Chang CC
    Arch Pathol Lab Med; 2009 Oct; 133(10):1594-9. PubMed ID: 19792049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of pre-transplant bone marrow plasma cell percentage on post-transplant response and survival in newly diagnosed multiple myeloma.
    Chakraborty R; Muchtar E; Kumar SK; Buadi FK; Dingli D; Dispenzieri A; Hayman SR; Hogan WJ; Kapoor P; Lacy MQ; Leung N; Gertz MA
    Leuk Lymphoma; 2017 Feb; 58(2):308-315. PubMed ID: 27390076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunophenotypic analysis of hematogones (B-lymphocyte precursors) in 662 consecutive bone marrow specimens by 4-color flow cytometry.
    McKenna RW; Washington LT; Aquino DB; Picker LJ; Kroft SH
    Blood; 2001 Oct; 98(8):2498-507. PubMed ID: 11588048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of hematogone presence after autologous stem cell transplantation in patients with multiple myeloma.
    Göçer M; Kurtoğlu E
    Cytometry B Clin Cytom; 2021 Nov; 100(6):645-651. PubMed ID: 33905180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Artifactual Kappa Light Chain Restriction of Marrow Hematogones: A Potential Diagnostic Pitfall in Minimal Residual Disease Assessment of Plasma Cell Myeloma Patients on Daratumumab.
    Jiang XY; Luider J; Shameli A
    Cytometry B Clin Cytom; 2020 Jan; 98(1):68-74. PubMed ID: 31313879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The significance of light chain-restricted bone marrow plasma cells after peripheral blood stem cell transplantation for multiple myeloma.
    Maia DM; Kell DL; Goates JJ; Warnke RA
    Am J Clin Pathol; 1997 Jun; 107(6):643-52. PubMed ID: 9169660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of bone marrow microvessel density and angiogenic cytokines in patients with multiple myeloma undergoing autologous stem cell transplant.
    Sucak GT; Aki SZ; Yüzbaşioğlu B; Akyürek N; Yağci M; Bağriaçik U; Haznedar R
    Leuk Lymphoma; 2011 Jul; 52(7):1281-9. PubMed ID: 21599578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of bone marrow plasma cells percentage on survival at diagnosis and pre-transplant period in newly diagnosed multiple myeloma: Experience of a single center from Turkey.
    Ciftciler R; Goker H; Buyukasık Y; Aladag E; Saglam EA; Demiroglu H
    Transfus Apher Sci; 2019 Jun; 58(3):313-317. PubMed ID: 30928228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of high-dose chemotherapy in the treatment of multiple myeloma: a controversy.
    Kyle RA
    Ann Oncol; 2000; 11 Suppl 1():55-8. PubMed ID: 10707780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hematogones with light chain restriction: A potential diagnostic pitfall when using flow cytometry analysis to assess bone marrow specimens.
    El Hussein S; Wang W; Wang SA; Fang H; Garces S; Tashakori M; Lyapichev KA; Qiu L; Wang X; Loghavi S; Medeiros LJ; Challagundla P; Jorgensen JL
    Leuk Res; 2021 Dec; 111():106704. PubMed ID: 34735934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autologous stem cell transplantation in elderly patients (> or =60 years) with diffuse large B-cell lymphoma: an analysis based on data in the European Blood and Marrow Transplantation registry.
    Jantunen E; Canals C; Rambaldi A; Ossenkoppele G; Allione B; Blaise D; Conde E; Tilly H; Cook G; Clark F; Gallamini A; Haynes A; Mounier N; Dreger P; Pfreundschuh M; Sureda A;
    Haematologica; 2008 Dec; 93(12):1837-42. PubMed ID: 18838474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of patients with multiple myeloma.
    Lemoli RM; Cavo M; Fortuna A
    J Hematother; 1996 Aug; 5(4):339-49. PubMed ID: 8877709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inspiration amidst the challenges: the first report of successful bone marrow transplantation in the Himalayan country Nepal.
    Sharma Poudyal B; Gyawali B; Tuladhar S; Kapali K; Shrestha GS
    Br J Haematol; 2016 Jun; 173(6):941-2. PubMed ID: 26303869
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.